A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
about
A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
description
clinical trial
@en
klinisch onderzoek
@nl
name
A Study of Safety, Tolerabilit ...... ate to Severe Plaque Psoriasis
@en
type
label
A Study of Safety, Tolerabilit ...... ate to Severe Plaque Psoriasis
@en
prefLabel
A Study of Safety, Tolerabilit ...... ate to Severe Plaque Psoriasis
@en
P17
P1050
P1476
A Phase 2, Multicenter, Open-L ...... ate to Severe Plaque Psoriasis
@en
P3098
NCT02576678
P580
2015-10-13T00:00:00Z
P582
2017-09-04T00:00:00Z